A major medical problem in CA is the growing population of individuals with neurodegenerative diseases, including Parkinson’s (PD) and Huntington’s (HD) disease. These diseases affect millions of people, sometimes during…
Ongoing degeneration of dopaminergic (DA) neurons in the midbrain is the hallmark of Parkinson’s disease (PD), a movement disorder that manifests with tremor, bradykinesia and rigidity. One million Americans live…
We proposes to use human embryonic stem cells (hESCs) differentiated into neural progenitor/stem cells (NPCs), but modified by transiently programming the cells with the transcription factor MEF2C to drive them…
Don't miss our video interview with Dr. Lorenz Studer, esteemed stem cell scientist at Sloan Kettering and winner of the 2017 Gladstone Institutes Ogawa-Yamanaka Stem Cell Prize. Read our blog…
Don't miss our video interview with Dr. Lorenz Studer, esteemed stem cell scientist at Sloan Kettering and winner of the 2017 Gladstone Institutes Ogawa-Yamanaka Stem Cell Prize. Read our blog…
Dr. Xianmin Zeng, associate professor at the Buck Institute for Research on Aging answers your questions about Parkinson's disease and stem cell research. Zeng has a CIRM research grant to…
